Decitabine shows anti-acute myeloid leukemia potential via regulating the miR-212-5p/CCNT2 axis

Decitabine shows anti-acute myeloid leukemia potential via regulating the miR-212-5p/CCNT2 axis

Previous research has revealed the involvement of microRNA-212-5p (miR-212-5p) and cyclin T2 (CCNT2) in acute myeloid leukemia (AML). However, whether the miR-212-5p/CCNT2 axis is required for the function of decitabine in AML has not been well elucidated. Quantitative reverse transcription-polymera...

Full description

Bibliographic Details
Main Authors: Xing Lina, Ren Jinhai, Guo Xiaonan, Qiao Shukai, Tian Tian
Format: Article
Language:English
Published: De Gruyter 2020-12-01
Series:Open Life Sciences
Subjects:
decitabine
mir-212-5p
aml
ccnt2
Online Access:https://doi.org/10.1515/biol-2020-0097

Internet

https://doi.org/10.1515/biol-2020-0097

Similar Items